je.st
news
Tag: drug
UPDATE 2-Ariad Pharma's lung cancer drug gets breakthrough therapy status
2014-10-03 05:53:42| Biotech - Topix.net
Ariad Pharmaceuticals Inc said its experimental lung cancer drug was granted "breakthrough therapy" status by the U.S. Food and Drug Administration and it expected to file for marketing approval in early 2016. The designation hastens the development and review of a drug that shows evidence of providing improvement over existing treatment for patients with serious diseases.
Tags: status
update
drug
cancer
Researchers Develop Faster Cancer Drug Discovery Platform
2014-10-02 13:28:25| drugdiscoveryonline News Articles
University of Michigan researchers have developed a new method for identifying potential cancer therapeutics that speeds up the traditionally slow drug discovery process. Using this new platform, the researchers were able to identify a novel antibody which is currently being evaluated as a potential treatment for breast, ovarian, and other cancers.
Tags: develop
drug
cancer
platform
MabVax Therapeutics Receives Orphan Drug Designation For Therapeutic Vaccine To Treat Childhood Cancer Neuroblastoma
2014-10-01 14:02:11| drugdiscoveryonline Home Page
MabVax Therapeutics Holdings, Inc. (OTCQB: TELKD), a clinical stage oncology drug development company, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's vaccine intended for the treatment of the childhood cancer neuroblastoma
Tags: drug
cancer
treat
receives
New Jersey Health Foundation Awards Grant To Enhance Drug Discovery At Rutgers University
2014-10-01 12:36:08| drugdiscoveryonline Home Page
In its continuing effort to advance the biomedical sciences, New Jersey Health Foundation (NJHF) has awarded a pivotal $35,000 grant to the Office of Translational Sciences at Rutgers, The State University of New Jersey, to help launch a Fragment Based Drug Discovery (FBDD) core facility
Tags: health
university
foundation
drug
UPDATE 1-Salix's constipation drug gets approval for expanded use
2014-09-30 04:30:30| Biotech - Topix.net
The injection, Relistor, has now been approved for use in patients on opioids for chronic pain unrelated to cancer, the company said on Monday. Relistor was first approved in 2008 to treat opioid-induced constipation in severely ill patients who did not respond to laxatives.
Tags: use
update
drug
expanded
Sites : [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] next »